427 material Form 8-K filings that 376 companies we cover made with the SEC in September 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Carrier Global appointed Beril Yildiz as Vice President, Controller and Chief Accounting Officer, effective when she starts on September 22, 2025. Patrick Goris, the company's CFO, has been serving as interim Controller since May 2, 2025 and will hand that role over on her start date while remaining Senior Vice President and Chief Financial Officer.
Beril Yildiz, age 47, previously was Senior Vice President, Controller and Chief Accounting Officer at International Flavors & Fragrances from September 2022 to August 2025
Yildiz's compensation includes a $500,000 annual base salary, a 60% target annual bonus, a $470,000 annual long-term incentive target, and a $750,000 sign-on equity grant
Yildiz also receives an $800,000 cash sign-on award and standard relocation expenses
Boston Scientific said Executive Vice President and President of Peripheral Interventions Jeffrey B. Mirviss will retire from that role effective December 1, 2025, and will then serve as a senior advisor through February 27, 2026. The company expects to sign a retirement agreement with him with payments and benefits materially consistent with existing plans, which matters to shareholders mainly as a routine leadership transition in one business unit.
Mirviss informed the company of his retirement decision on August 29, 2025.
Retirement from his executive role takes effect December 1, 2025.
He will stay on as a senior advisor until the Retirement Date, no later than February 27, 2026, at his current $705,000 annual base salary, prorated.
A Retirement Agreement is expected, with terms materially consistent with existing executive retirement, bonus and long-term incentive plans.
Coca-Cola Consolidated said Executive Vice President of Franchise Beverage Operations Robert G. Chambless plans to retire in 2027 and will transition to Executive Vice President, Senior Advisor to the Chairman and CEO, effective January 1, 2026. The filing says the change is not the result of any disagreement with the company on operations, policies, practices, financial statements, accounting policies or internal controls.
Robert G. Chambless notified the company of his retirement plans on August 28, 2025.
Chambless will move to the Senior Advisor role effective January 1, 2026, and retire in 2027.
In the new role he will help with transition matters and serve as strategic advisor to the Chairman and CEO.
The filing states no disagreement with the company on financial statements, accounting or internal controls.
LivaNova's board appointed Donald Zurbay, former CEO and CFO of Patterson Companies, as a director effective September 4, 2025, and as a member of the Audit and Compliance Committee. The filing describes his prior roles at Patterson Companies and St. Jude Medical and lists his director compensation, which is prorated until the 2026 Annual General Meeting.
Donald Zurbay joins the board and Audit and Compliance Committee; his term begins September 4, 2025.
He was President and CEO of Patterson Companies from October 2022 until May 2025, and its CFO from June 2018 to October 2022.
Annual compensation includes a $70,000 board retainer, a $15,000 committee member fee, and restricted stock with a fair market value of $185,000, prorated to the 2026 Annual General Meeting.
Genuine Parts Company entered into a Cooperation Agreement with Elliott Investment Management and appointed Matthew A. Carey and Court D. Carruthers to its Board effective September 4, 2025, while directors John R. Holder and Robin C. Loudermilk, Jr. retired. The filing also discloses new retention restricted stock units and a form of severance agreement for executives, which shareholders may weigh as part of the company's governance changes.
Carey and Carruthers joined the Board as independent directors, with initial terms expiring at the 2026 annual meeting; Carey joined the Audit Committee and Carruthers joined the Compensation and Human Capital Committee.
Holder and Loudermilk retired from the Board effective September 4, 2025, and the company said their decisions were not due to any disagreement with the company.
Retention RSU grants have a grant date value of $3.0 million for CEO Will Stengel and $1.5 million for each of CFO Bert Nappier, Naveen Krishna and Christopher Galla, cliff vesting on the third anniversary of the grant date.
The cooperation period runs until the earlier of 30 days before the 2027 annual meeting nomination deadline or September 4, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.